Some insurers and TPAs do simply refuse to provide data, but, much more often, they will put up less obvious barriers, according to one House committee witness.
As medical and pharmacy expenses climb, large employers are adjusting plan design, limiting drug spending growth and expanding targeted support like caregiving and financial wellness benefits.
Wednesday, July 22, 2026 at 2:00 pm ET <br><br> In this panel, benefits and healthcare leaders will explore how employers can evaluate women's and family health benefits through the lens of clinical outcomes, total cost of care, and workforce impact, while identifying what distinguishes truly integrated, outcomes-driven solutions from traditional coverage-focused offerings.
